Published online June 1, 2006
PEDIATRICS Vol. 117 No. 6 June 2006, pp. 1887-1892 (doi:10.1542/peds.2005-2351)
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via ISI Web of Science (18)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Malek, M. A.
Right arrow Articles by Parashar, U. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Malek, M. A.
Right arrow Articles by Parashar, U. D.
Related Collections
Right arrow Infectious Disease & Immunity

Diarrhea- and Rotavirus-Associated Hospitalizations Among Children Less Than 5 Years of Age: United States, 1997 and 2000

Mark A. Malek, MDa, Aaron T. Curns, MPHb, Robert C. Holman, MSb, Thea K. Fischer, MDa, Joseph S. Bresee, MDa, Roger I. Glass, MDa, Claudia A. Steiner, MDc and Umesh D. Parashar, MDa

a Respiratory and Enteric Virus Branch
b Office of Director, Division of Viral and Rickettsial Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia
c Healthcare Cost and Utilization Project, Center for Delivery, Organization and Markets, Agency for Healthcare Research and Quality, US Department of Health and Human Services, Rockville, Maryland

OBJECTIVE. A new rotavirus vaccine may be licensed in the United States in early 2006. Estimates of the burden of severe rotavirus disease, particularly hospitalizations, will help evaluate the potential benefits of a national rotavirus immunization program.

DESIGN. The Kids' Inpatient Database, a robust sample of 10% of the uncomplicated births and 80% of other pediatric discharges was used to estimate the number and rate of diarrhea- and rotavirus-associated hospitalizations among US children <5 years of age in 1997 and 2000.

RESULTS. In 1997 and 2000, diarrhea was coded in 13% of all childhood hospitalizations, for an estimated cumulative incidence of 1 diarrhea hospitalization per 23 to 27 children by age 5. Most diarrhea-associated hospitalizations (62%) were coded as unspecified etiology, and 35% as viral. Rotavirus was the most common pathogen recorded for 18% and 19% of diarrhea-associated hospitalizations in 1997 and 2000, respectively. Diarrhea-associated hospitalizations coded as unspecified or viral exhibited a marked winter peak similar to that of hospitalizations coded as rotavirus, suggesting that the rotavirus-specific code captures a fraction of all rotavirus hospitalizations. Using indirect methods, we estimated that rotavirus was associated with 51142–60155 and 46839–56820 hospitalizations in 1997 and 2000, respectively. By these estimates, rotavirus is associated with 4% to 5% of all childhood hospitalizations, and 1 in 67 to 1 in 85 children will be hospitalized with rotavirus by 5 years of age.

CONCLUSIONS. Diarrhea is an important cause of hospitalization in US children, and rotavirus is the most important etiology. Disease burden estimates have remained stable during the past decade. An effective rotavirus vaccine will likely reduce substantially the burden of severe rotavirus disease, estimated to account for 4% to 5% of all hospitalizations and ~30% of hospitalizations for watery diarrhea among children <5 years of age.

Key Words: diarrhea • vaccines • gastroenteritis • rotavirus • hospitalization

Abbreviations: NHDS—National Hospital Discharge Survey • KID—Kids' Inpatient Database • ICD-9-CM—International Classification of Diseases—Ninth Revision—Clinical Modification

Accepted Nov 16, 2005.




This article has been cited by other articles:


Home page
 Arch Pediatr Adolesc MedHome page
L. R. DeCamp, J. S. Byerley, N. Doshi, and M. J. Steiner
Use of Antiemetic Agents in Acute Gastroenteritis: A Systematic Review and Meta-analysis
Arch Pediatr Adolesc Med, September 1, 2008; 162(9): 858 - 865.
[Abstract] [Full Text] [PDF]

Home page
 Arch Pediatr Adolesc MedHome page
R. C. Vreeman, S. M. E. Finnell, E. R. Cernkovich, and A. E. Carroll
The Effects of Antiemetics for Children With Vomiting Due to Acute, Moderate Gastroenteritis
Arch Pediatr Adolesc Med, September 1, 2008; 162(9): 866 - 869.
[Full Text] [PDF]

Home page
 CLIN PEDIATRHome page
K. S. Reisinger and S. L. Block
Characteristics of an Ideal Rotavirus Vaccine
Clinical Pediatrics, July 1, 2008; 47(6): 555 - 563.
[Abstract] [PDF]

Home page
 CLIN PEDIATRHome page
L. M. Jacobson, M. Santosham, and A. M. Milstone
Pediatric Providers' Acceptance of Recommendations for Routine Rotavirus Vaccination
Clinical Pediatrics, June 1, 2008; 47(5): 500 - 503.
[PDF]

Home page
 PediatricsHome page
J. E. Tate, L. Simonsen, C. Viboud, C. Steiner, M. M. Patel, A. T. Curns, and U. D. Parashar
Trends in Intussusception Hospitalizations Among US Infants, 1993-2004: Implications for Monitoring the Safety of the New Rotavirus Vaccination Program
Pediatrics, May 1, 2008; 121(5): e1125 - e1132.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Microbiol. Rev.Home page
P. H. Dennehy
Rotavirus Vaccines: an Overview
Clin. Microbiol. Rev., January 1, 2008; 21(1): 198 - 208.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Microbiol.Home page
S.-Y. Chen, Y.-C. Chang, Y.-S. Lee, H.-C. Chao, K.-C. Tsao, T.-Y. Lin, T.-Y. Ko, C.-N. Tsai, and C.-H. Chiu
Molecular Epidemiology and Clinical Manifestations of Viral Gastroenteritis in Hospitalized Pediatric Patients in Northern Taiwan
J. Clin. Microbiol., June 1, 2007; 45(6): 2054 - 2057.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
S. M. Storey, T. F. Gibbons, C. V. Williams, R. D. Parr, F. Schroeder, and J. M. Ball
Full-Length, Glycosylated NSP4 Is Localized to Plasma Membrane Caveolae by a Novel Raft Isolation Technique
J. Virol., June 1, 2007; 81(11): 5472 - 5483.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
M.-A. Widdowson, M. I. Meltzer, X. Zhang, J. S. Bresee, U. D. Parashar, and R. I. Glass
Cost-effectiveness and Potential Impact of Rotavirus Vaccination in the United States
Pediatrics, April 1, 2007; 119(4): 684 - 697.
[Abstract] [Full Text] [PDF]

Home page
 AAP Grand RoundsHome page
J. Snyder
Rotavirus Vaccine: Who Will Benefit?
AAP Grand Rounds, January 1, 2007; 17(1): 5 - 6.
[Full Text] [PDF]

Home page
 Journal of Pharmacy PracticeHome page
K. K. Orr, K. L. Matson, and B. J. Cowles
Nonprescription Medication Use by Infants and Children: Product Labeling Versus Evidence-Based Medicine
Journal of Pharmacy Practice, October 1, 2006; 19(5): 286 - 294.
[Abstract] [PDF]